|
Ä¿¸®¾îÄɾî |
´Ù±¹Àû Á¦¾àȸ»ç MSL(oncology)
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
5³â¡è |
ä¿ë½Ã |
01.02 |
|
|
HR ÄÁ¼³Æà |
À¯¸í ÄÚ½º´Ú Á¦¾à»ç Ç°Áú°ü¸® ä¿ë
¼¿ï ±Ýõ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
5³â¡è |
ä¿ë½Ã |
12.13 |
|
|
Ä¿¸®¾îÄɾî |
´Ù±¹ÀûÁ¦¾àȸ»ç CPL (Clinical Project Leader)
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
6³â¡è |
ä¿ë½Ã |
09.27 |
|
|
DREAMHR |
ÇコÄɾî QA ¸Å´ÏÀú ºÎÀå±Þ
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
5³â¡è |
ä¿ë½Ã |
03.31 |
|
|
(ÁÖ)ÄھƼġ |
Sr.product manager
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
8³â¡è |
ä¿ë½Ã |
12.01 |
|
|
(ÁÖ)¸¶ÀÌ´õ½º¿¡ÀÌÄ¡¾Ë |
[¿Ü±¹°è ±Û·Î¹ú Á¦¾à/¹ÙÀÌ¿À ±â¾÷] Supply Chain Specialist
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ý»êÁö¿ø/¹°·ù/±¸¸Å |
5³â¡è |
ä¿ë½Ã |
07.28 |
|
|
(ÁÖ)ÄھƼġ |
Clinical Quality&Training Manager
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
ä¿ë½Ã |
12.28 |
|
|
Ä¿¸®¾îÄɾî |
Medical Operation Sr.Manager (Regional Role) º»ºÎÀå
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
5³â¡è |
ä¿ë½Ã |
09.02 |
|
|
Ä¿¸®¾îÄɾî |
±Û·Î¹ú Á¦¾à»ç Pharmacy Brand Manager
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
5³â¡è |
ä¿ë½Ã |
08.16 |
|
|
(ÁÖ)½ºÄ«¿ìÆ®ÆÄÆ®³Ê½º |
Bio-marker ±â¼ú°³¹ß ¶Ç´Â ÀÓ»ó½ÃÇè ¶Ç´Â ÀÎÇã°¡ °æ·ÂÀÚ(ÃÊ
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
04.18 |
|
|
ÈÞ¸Ó·¹ÀÎÄÁ¼³Æà |
±ä±Þ) ±¹³» Á¾ÇÕº´¿ø - Ç÷¾×Á¾¾ç³»°ú (°æºÏ ±Ù¹«) - ÃÖ¿ì´ë
°æºÏ ÀüÁö¿ª | ´ëÇпø(¼®»ç) Á¹¾÷ |
˂ȍ |
5³â¡è |
ä¿ë½Ã |
09.27 |
|
|
Ä¿¸®¾îÄɾî |
´Ù±¹ÀûÁ¦¾à»ç Rheumatology PM
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
5³â¡è |
ä¿ë½Ã |
02.10 |
|
|
¿¡´Ï±×¸¶ÄÁ¼³ÆÃ(ÁÖ) |
Training Specialist-¿Ü±¹°è ´Ù±¹Àû Á¦¾à»ç
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
5³â¡è |
ä¿ë½Ã |
08.07 |
|
|
Ä¿¸®¾îÄɾî |
±Û·Î¹ú Á¦¾àȸ»ç Project Manager (Àü·«)
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¼ö½Ãä¿ë |
5³â¡è |
ä¿ë½Ã |
06.24 |
|
|
Çì´Ï¾Ø¸ÓÄÚÀÌ |
Pharmacovigilance (MI) Specialist / Regulatory Affairs
¼¿ï °³²±¸, ¼¿ï ¼ÛÆı¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
5³â¡è |
ä¿ë½Ã |
03.14 |
|